(CAG) ConAgra Foods - Ratings and Ratios
Frozen Meals, Shelf-Stable Entrees, Snacks, Baking Mixes, Whipped Toppings
CAG EPS (Earnings per Share)
CAG Revenue
Description: CAG ConAgra Foods November 04, 2025
Conagra Brands, Inc. (NYSE:CAG) is a U.S.–based consumer packaged goods company that sells a broad portfolio of shelf-stable, refrigerated, and frozen foods across four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. Its brands-including Birds Eye, Marie Callender’s, Duncan Hines, Healthy Choice, Slim Jim, Reddi-Wip, Angies, and BOOMCHICKAPOP-are distributed through grocery retailers, club stores, e-commerce platforms, and foodservice outlets, with the International segment extending these offerings outside the United States.
Key performance indicators to watch include the 12-month trailing same-store sales growth in the Grocery & Snacks segment (historically 2-4% YoY) and the contribution margin expansion from the Refrigerated & Frozen segment, which has benefited from higher pricing power amid rising commodity costs. Macro drivers such as U.S. consumer discretionary spending trends, inflation-adjusted food price indices, and the shift toward “convenient at-home” meals continue to shape demand, while the ongoing supply-chain bottlenecks in cold-storage logistics present both risk and upside for margin improvement.
For a deeper, data-driven assessment of Conagra’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
CAG Stock Overview
| Market Cap in USD | 8,314m |
| Sub-Industry | Packaged Foods & Meats |
| IPO / Inception | 1984-09-07 |
CAG Stock Ratings
| Growth Rating | -78.1% |
| Fundamental | 47.3% |
| Dividend Rating | 81.6% |
| Return 12m vs S&P 500 | -43.2% |
| Analyst Rating | 3.16 of 5 |
CAG Dividends
| Dividend Yield 12m | 8.17% |
| Yield on Cost 5y | 5.10% |
| Annual Growth 5y | 11.25% |
| Payout Consistency | 97.7% |
| Payout Ratio | 67.3% |
CAG Growth Ratios
| Growth Correlation 3m | -81% |
| Growth Correlation 12m | -94.2% |
| Growth Correlation 5y | -60.4% |
| CAGR 5y | -16.80% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.32 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.67 |
| Sharpe Ratio 12m | -1.93 |
| Alpha | -41.70 |
| Beta | 0.037 |
| Volatility | 27.31% |
| Current Volume | 10833.1k |
| Average Volume 20d | 10988.4k |
| Stop Loss | 16.6 (-3.2%) |
| Signal | -0.45 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (850.1m TTM) > 0 and > 6% of Revenue (6% = 687.0m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -1.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.84% (prev -1.93%; Δ 3.77pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 1.54b > Net Income 850.1m (YES >=105%, WARN >=100%) |
| Net Debt (7.58b) to EBITDA (1.91b) ratio: 3.97 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (479.6m) change vs 12m ago -0.15% (target <= -2.0% for YES) |
| Gross Margin 25.35% (prev 27.46%; Δ -2.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 53.99% (prev 56.20%; Δ -2.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.74 (EBITDA TTM 1.91b / Interest Expense TTM 407.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.42
| (A) 0.01 = (Total Current Assets 3.84b - Total Current Liabilities 3.63b) / Total Assets 21.17b |
| (B) 0.32 = Retained Earnings (Balance) 6.76b / Total Assets 21.17b |
| (C) 0.07 = EBIT TTM 1.52b / Avg Total Assets 21.21b |
| (D) 0.79 = Book Value of Equity 9.69b / Total Liabilities 12.26b |
| Total Rating: 2.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.30
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 7.18% = 3.59 |
| 3. FCF Margin 9.96% = 2.49 |
| 4. Debt/Equity 0.93 = 2.09 |
| 5. Debt/Ebitda 3.97 = -2.50 |
| 6. ROIC - WACC (= 1.66)% = 2.08 |
| 7. RoE 9.60% = 0.80 |
| 8. Rev. Trend -69.92% = -5.24 |
| 9. EPS Trend -79.88% = -3.99 |
What is the price of CAG shares?
Over the past week, the price has changed by -0.29%, over one month by -7.50%, over three months by -9.13% and over the past year by -35.28%.
Is ConAgra Foods a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CAG is around 15.20 USD . This means that CAG is currently overvalued and has a potential downside of -11.32%.
Is CAG a buy, sell or hold?
- Strong Buy: 0
- Buy: 3
- Hold: 16
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CAG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.5 | 19.7% |
| Analysts Target Price | 20.5 | 19.7% |
| ValueRay Target Price | 16.2 | -5.7% |
CAG Fundamental Data Overview October 30, 2025
P/E Trailing = 9.8192
P/E Forward = 10.8696
P/S = 0.7261
P/B = 1.029
P/EG = 12.0743
Beta = 0.037
Revenue TTM = 11.45b USD
EBIT TTM = 1.52b USD
EBITDA TTM = 1.91b USD
Long Term Debt = 7.22b USD (from longTermDebt, last quarter)
Short Term Debt = 1.06b USD (from shortTermDebt, last quarter)
Debt = 8.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.58b USD (from netDebt column, last quarter)
Enterprise Value = 15.90b USD (8.31b + Debt 8.28b - CCE 698.1m)
Interest Coverage Ratio = 3.74 (Ebit TTM 1.52b / Interest Expense TTM 407.6m)
FCF Yield = 7.18% (FCF TTM 1.14b / Enterprise Value 15.90b)
FCF Margin = 9.96% (FCF TTM 1.14b / Revenue TTM 11.45b)
Net Margin = 7.42% (Net Income TTM 850.1m / Revenue TTM 11.45b)
Gross Margin = 25.35% ((Revenue TTM 11.45b - Cost of Revenue TTM 8.55b) / Revenue TTM)
Gross Margin QoQ = 24.33% (prev 25.65%)
Tobins Q-Ratio = 0.75 (Enterprise Value 15.90b / Total Assets 21.17b)
Interest Expense / Debt = 1.16% (Interest Expense 95.7m / Debt 8.28b)
Taxrate = 43.10% (124.6m / 289.1m)
NOPAT = 866.9m (EBIT 1.52b * (1 - 43.10%))
Current Ratio = 1.06 (Total Current Assets 3.84b / Total Current Liabilities 3.63b)
Debt / Equity = 0.93 (Debt 8.28b / totalStockholderEquity, last quarter 8.92b)
Debt / EBITDA = 3.97 (Net Debt 7.58b / EBITDA 1.91b)
Debt / FCF = 6.65 (Net Debt 7.58b / FCF TTM 1.14b)
Total Stockholder Equity = 8.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.02% (Net Income 850.1m / Total Assets 21.17b)
RoE = 9.60% (Net Income TTM 850.1m / Total Stockholder Equity 8.86b)
RoCE = 9.47% (EBIT 1.52b / Capital Employed (Equity 8.86b + L.T.Debt 7.22b))
RoIC = 5.07% (NOPAT 866.9m / Invested Capital 17.10b)
WACC = 3.41% (E(8.31b)/V(16.59b) * Re(6.15%) + D(8.28b)/V(16.59b) * Rd(1.16%) * (1-Tc(0.43)))
Discount Rate = 6.15% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF Debug] Terminal Value 79.86% ; FCFE base≈1.27b ; Y1≈1.42b ; Y5≈1.90b
Fair Price DCF = 68.80 (DCF Value 32.91b / Shares Outstanding 478.4m; 5y FCF grow 14.02% → 3.0% )
EPS Correlation: -79.88 | EPS CAGR: -27.07% | SUE: 0.0 | # QB: 0
Revenue Correlation: -69.92 | Revenue CAGR: -8.02% | SUE: 0.36 | # QB: 0
Additional Sources for CAG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle